Research into autoimmune treatment is yielding new therapies, with various companies and organizations exploring data-driven approaches to transform patient outcomes for conditions such as inflammatory bowel diseases and multiple sclerosis. The development of precision therapies is a key area of focus, with some aiming to reset the immune system. The involvement of patient partners in research and the search for treatments for previously untreated diseases, including skin diseases, are also part of the broader effort to advance immunology.